Tenders › Countries › Germany › Health & social work

Germany – Health services – Central Laboratory Services for Clinical Trial

BiconY Therapeutics GmbH · Leipzig, Germany Closes in 28d

Summary

The Federal Agency for Disruptive Innovation - SPRIND GmbH ("SPRIND") - aims to create new disruptive innovations from Germany. That means products, services and systems that make all our lives noticeably and sustainably better. To achieve this, SPRIND brings together new thinkers from science and business, people with outstanding ideas, special expertise, and passion. Hence, SPRIND provides an entrepreneurial environment that turns ideas into reality. The objective of BiconY Therapeutics GmbH, a SPRIND subsidiary, is the development of a bispecific antibody combination for the treatment of solid tumours. The combination consists of proprietary, bispecific CD3 anti-bodies (bsAbCD3) and bispecific CD28 co-stimulators (BiCos), which, when used together, significantly improve the specificity, sustainability, and efficiency of a T cell recruitment and thus the immune response against tumour…

How to bid

1. Open the official notice on TED (688024-2026) and download the procurement documents linked there — the full specification, award criteria and any lots.
2. Check you can take part: this is an open procedure for services, so review the selection criteria (turnover, references, certifications) before investing time.
3. Submit through the buyer's e-procurement portal before 4 November 2026, 11:00 CET. Late submissions are rejected automatically — set a reminder a week ahead for questions and a day ahead for upload.

Related open tenders

Browse all health & social work tenders in Germany · All open tenders in Germany